A comprehensive framework identifying barriers to global health R&D innovation and access

Author:

Ong MingORCID

Abstract

Advancements in research and development (R&D) have the potential to address pressing global health challenges. However, numerous barriers hinder innovation and access, particularly in areas of market failure, and there is an absence of a cohesive consensus on defining these various impediments. This paper presents a framework identifying the barriers that impede global health innovation and hinder equitable access to health technologies.The framework presents clear typologies of barriers across global health R&D thematic areas. These include the market failures that require R&D incentives to stimulate innovation, how the complexity of product registration hinders access within specific regulatory domains and how health system implementation issues prevent affected populations from accessing the tools they require. Current and historical examples are provided for each end-point, and three case studies explore key barriers and how solutions have or may be applied.This analysis contributes by adding to the body of knowledge on global health R&D and provides an analysis tool to policy-makers, researchers and stakeholders involved in addressing the barriers and promoting equitable access to healthcare innovations. The framework serves as a practical tool to guide future research, policy development and implementation efforts towards achieving sustainable global health outcomes.

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference50 articles.

1. Access to medicines, market failure and market intervention: a tale of two regimes;Williams;Glob Public Health,2012

2. Tenni B , Moir HVJ , Townsend B , et al . What is the impact of intellectual property rules on access to medicines? A systematic review. Global Health 2022;18. doi:10.1186/s12992-022-00826-4

3. Motari M , Nikiema J-B , Kasilo OMJ , et al . The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement. BMC Public Health 2021;21:490. doi:10.1186/s12889-021-10374-y

4. Silverman AT Jason M , ed. J&J expands global access to TB drug as popular novelist joins advocacy campaign [Internet]. STAT; 2023. Available: https://www.statnews.com/2023/07/14/tb-drug-bedaquiline-johnson-and-johnson-john-green/

5. Lin R . The value of product development partnerships [Internet]. 2014. Available: https://www.nbr.org/publication/the-value-of-product-development-partnerships/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3